Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
SUVENPHAR Stock Analysis
Views
Red Flags
Positive
Strong revenue growth and above median growth of industry
Low Debt to Equity, not much change from last year
Negative
Expensive and at a premium to industry median P/E
Weak price momentum
Analysts have been downgrading forward EPS estimates
Low and declining ROE
Low EPS growth and lower than median growth of industry
Low dividend yield
Neutral
High operating margin but declining trend
Company's earnings are of moderate quality
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
SUVENPHAR Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
SUVENPHAR Bulk, Block & Insider Trades
SUVENPHAR Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Bonus
Bonus(1 new shares for 1 existing shares) Ex-date: 25th Sep 2020 Announced on: 17th Aug 2020
Company Profile
Cohance Lifesciences Limited, formerly Suven Pharmaceuticals Limited, is an India-based technology-driven contract development and manufacturing organization (CDMO), providing integrated solutions in custom synthesis, process research and development (R&D), and manufacturing. The Company’s business ... Read More
Key personnel
Mr. Vivek SharmaD
Executive Chairman of the Board
Mr. Yann Dherve
Chief Executive Officer
Mr. Himanshu AgarwalD
Chief Financial Officer, Whole-time Director
Mr. Kundan Kumar Jha
Compliance Officer, Company Secretary, Head- Legal
Ms. Shweta JalanD
Non-Executive Director
Mr. Vinod PadikkalD
Non-Executive Director
Mr. Pankaj PatwariD
Non-Executive Director
Mr. Kumarapuram Gopalakrishnan AnanthakrishnanD
Non-Executive Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Cohance Lifesciences Ltd.?
The current share price of Cohance Lifesciences Ltd. is ₹ 475.40 as of 09 Jan 2026.
What is the PE ratio of Cohance Lifesciences Ltd.?
The Price-to-Earnings (PE) ratio of Cohance Lifesciences Ltd. is 73.38 as of the latest financial data.
What is the ROE and ROCE of Cohance Lifesciences Ltd.?
Cohance Lifesciences Ltd. has a Return on Equity (ROE) of 8.60% and a Return on Capital Employed (ROCE) of 8.94% as per the latest financial reports.
What is the market cap of Cohance Lifesciences Ltd.?
The market capitalization of Cohance Lifesciences Ltd. stands at ₹ 18,187.20 Cr.
What is the dividend yield of Cohance Lifesciences Ltd.?
The dividend yield of Cohance Lifesciences Ltd. is 0.00% based on the current market price.
What is the RSI of Cohance Lifesciences Ltd.?
The Relative Strength Index (RSI) of Cohance Lifesciences Ltd. is 16.80.
What is the FII and DII holding in Cohance Lifesciences Ltd.?
Foreign Institutional Investors (FII) hold 6.51% and Domestic Institutional Investors (DII) hold 20.44% of Cohance Lifesciences Ltd. shares.
What sector does Cohance Lifesciences Ltd. belong to?
Cohance Lifesciences Ltd. operates in the Healthcare sector.
What is the beta of Cohance Lifesciences Ltd. stock?
The beta of Cohance Lifesciences Ltd. stock is 0.62, indicating its volatility relative to the broader market.
